Economic valuation of amitriptyline, desipramine, nortriptyline, and sertraline in the management of patients with depression

Johnson, 1992, Service utilization and social morbidity associated with depressive symptoms in the community, JAMA, 267, 1478, 10.1001/jama.1992.03480110054033 Conti, 1994, The economic impact of depression in a workplace, J Occup Med., 36, 983 Jonsson, 1994, What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment, Br J Psychiatry, 164, 665, 10.1192/bjp.164.5.665 Strum, 1995, How can care for depression become more cost-effective, JAMA, 273, 51, 10.1001/jama.1995.03520250067036 Henry, 1993, Debits and credits in the management of depression, Br J Psychiatry, 20, 33, 10.1192/S0007125000292350 Greenberg, 1993, The economic burden of depression in 1990, J Clin Psychiatry, 54, 405 Dechant, 1991, Paroxetine: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in depressive illness, Drugs, 41, 225, 10.2165/00003495-199141020-00007 Murdoch, 1992, Sertraline: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in depression and obsessive-compulsive disorder, Drugs, 44, 604, 10.2165/00003495-199244040-00007 Stokes, 1993, Fluoxetine: A five-year review, Clin Ther, 15, 216 Kasper, 1992, Comparative efficacy of antidepressants, Drugs, 43, 11, 10.2165/00003495-199200432-00004 Potter, 1991, The pharmacologic treatment of depression, NEJM, 325, 633, 10.1056/NEJM199108293250907 Nemeroff, 1994, Evolutionary trends in the pharmacotherapeutic management of depression, J Clin Psychiatry, 55, 3 Andrews, 1994, Contemporary management of depression, Am J Med, 97, 24S, 10.1016/0002-9343(94)90360-3 Casey, 1994, Striking a balance between safety and efficacy: Experience with the SSRI sertraline, Int Clin Psychopharmacolo, 9, 5, 10.1097/00004850-199406003-00002 Schatzberg, 1991, Dosing strategies for antidepressant agents, J Clin Psychiatry, 52, 14 Tollefson, 1991, Antidepressant treatment and side effect considerations, J Clin Psychiatry, 52, 4 Chan, 1987, Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants, J Clin Psychiatry, 48, 197 Baldessarini, 1989, Current status of antidepressants: Clinical pharmacology and therapy, J Clin Psychiatry, 50, 117 Haddad, 1992, Managing tricyclic antidepressant overdose, Am Fam Phys, 46, 153 1994, Agency for Health Care Policy and Research, 2 Kupfer, 1991, Long-term treatment of depression, J Clin Psychiatry, 52, 28 Turner, 1994, Quality of life: Experience with sertraline, Int Clin Psychopharmacol, 9, 27, 10.1097/00004850-199406003-00005 Skaer, 1993, Applying pharmacoeconomic and quality-of-life measures to the formulary management process, Hosp Formul, 28, 577